Voyageur Pharmaceuticals (VM) News Today C$0.06 -0.01 (-7.69%) (As of 11/22/2024 05:18 PM ET) Add Compare Share Share Headlines Stock AnalysisChart All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period One of the best Venture pharma stocks has grown even strongerOctober 3, 2024 | msn.comVoyageur Pharmaceuticals Ltd (VM)August 10, 2024 | investing.comUpdate - Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium ContrastMay 28, 2024 | finance.yahoo.comVoyageur Pharmaceuticals executes royalty agreement with Rain Cage CarbonMarch 13, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals Ltd VMJanuary 3, 2024 | morningstar.comVoyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to DirectorsDecember 21, 2023 | stockhouse.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Thursday (VM)December 8, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Monday (VM)October 24, 2023 | theglobeandmail.comVoyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast MediaSeptember 14, 2023 | stockhouse.comVoyageur Pharmaceuticals achieves milestone developing HDXBa barium contrast mediaSeptember 14, 2023 | proactiveinvestors.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Wednesday (VM)September 7, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Tuesday (VM)June 20, 2023 | theglobeandmail.comVoyageur Pharmaceuticals completes field work at Frances Creek project in British ColumbiaMay 31, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast DrugsMay 24, 2023 | finance.yahoo.comVoyageur Pharmaceuticals unveils pioneering agreement with Rain Cage CarbonMay 24, 2023 | proactiveinvestors.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Tuesday (VM)May 10, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Wednesday (VM)May 4, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Monday (VM)May 2, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Friday (VM)April 29, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Thursday (VM)April 28, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Monday (VM)April 26, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Friday (VM)April 22, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Thursday (VM)April 21, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Friday (VM)April 14, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Wednesday (VM)April 8, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Tuesday (VM)April 6, 2023 | theglobeandmail.comVoyageur Pharmaceuticals reports positive comparative study of SmoothX barium contrast media for CT imagingApril 4, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals preparing to launch sales of its first product in CanadaFebruary 14, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals Ltd. (VM.V)February 10, 2023 | finance.yahoo.comVoyageur Pharmaceuticals completes second and final closing of its private placement for gross proceeds of $1,019,953.53January 23, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals launches SmoothX barium contrast media in CanadaDecember 8, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals issues deferred share units to directors under equity incentive compensation planDecember 5, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals Ltd. Announces Equity Incentive CompensationDecember 3, 2022 | yahoo.comVoyageur Pharmaceuticals completes design for Alberta's first carbon-neutral pharmaceutical facilityNovember 1, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals Ltd. Designs Carbon Neutral Pharmaceutical Manufacturing Plant with a Carbon Credit De-Carbonization Strategy for CustomersOctober 31, 2022 | finance.yahoo.comVoyageur Pharmaceuticals LtdAugust 21, 2022 | reuters.comVoyageur Pharmaceuticals Ltd. Announces Increase to Proposed Private PlacementMay 31, 2022 | stockhouse.comVoyageur Pharmaceuticals Ltd. Announces Issuance of Shares to Pay for Deposits and DebtMay 10, 2022 | stockhouse.comVoyageur Pharmaceuticals Announces Shareholder Update and Filing of Frances Creek Preliminary Economic Assessment ReportFebruary 24, 2022 | stockhouse.comVoyageur Pharmaceuticals Ltd VYYRFJanuary 30, 2022 | stockhouse.comVoyageur Pharmaceuticals Provides Update on PEA Progress & Takes a Major Step Towards Production Start UpDecember 6, 2021 | stockhouse.comVoyageur Pharmaceuticals Ltd., Announces The Creation of a New Scientific Advisory Board With World Class Leading PhysiciansSeptember 15, 2021 | benzinga.comVoyageur Pharmaceuticals Ltd. Announces Issuance of Stock Options and Deferred Share UnitsAugust 12, 2021 | stockhouse.com Get Voyageur Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VM and its competitors with MarketBeat's FREE daily newsletter. Email Address War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. VM Media Mentions By Week VM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VM News Sentiment▼0.000.49▲Average Medical News Sentiment VM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VM Articles This Week▼00▲VM Articles Average Week Get Voyageur Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MediPharm Labs News Today Charlotte's Web News Today Decibel Cannabis News Today Crescita Therapeutics News Today Willow Biosciences News Today Medicure News Today Indiva News Today Valeo Pharma News Today Entourage Health News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:VM) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyageur Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyageur Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VM Stock Alerts